How to Control Impurities during API drug manufacturing
Posted: February 19, 2018
Dr. Rajesh Shukla, Vice President Research and Development at PCI Synthesis Talks about Controlling Impurities during API drug manufacturing.
Related posts:
How to Know when to Toss your Prescription Drug or Refrigerate it
Innovative Approaches to Bring More Affordable Drugs to Market Faster
Did Your API Project Exceed Budget? Here’s Why
Don’t Let Failure to Communicate Get in the Way of Effective Technology Transfer in API Manufacturin...
The Keys to Optimizing Process Research